Legend Biotech Corp
Change company Symbol lookup
Select an option...
LEGN Legend Biotech Corp
$NQUSL50206015GBPN Nasdaq Large Cap Commercial Vehicles
BTSR Brightstar Information Technology Group Inc
RL Ralph Lauren Corp
FOXA Fox Corp
EVOK Evoke Pharma Inc
FSK FS KKR Capital Corp
SNTI Senti Biosciences Inc
ACR Acres Commercial Realty Corp
SSU SIGNA Sports United NV
Go

Health Care : Biotechnology |
Company profile

Legend Biotech Corporation is a global biotechnology company, which is focused on developing, manufacturing and commercializing novel therapies to treat life-threatening diseases. The Company is developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), is a CAR-T cell therapy for the treatment of multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also developing an allogeneic gamma delta CAR-T product candidate targeting B-cell maturation antigen for MM.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$64.90
Day's Change
-2.27 (-3.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
67.16
Day's Low
63.85
Volume
(Average)
Volume:
517,267

10-day average volume:
495,626
517,267
  • Prev Close
    67.17
  • Today's Open
    67.16
  • Day's Range
    63.85-67.16
  • Avg Vol (10-day)
    495.6K
  • Last (time)
    3:59p ET 10/02/23
  • Last (size)
    87.3K
  • 52-Wk Range
    37.30 - 77.32
    LowHigh
  • (10/12/22 - 07/21/23)
    16.06%
  • 45.3%
  • Market Cap
    11.8B
  • Shares Outstanding
    182.3M
  • -3.16
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 46.64
  • (% of float 09/15/23)
    4.03

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.